Blog
National Vision and Smart Glasses: Early Investing Signals
National Vision EYE is trying to prove a value optical model can still grow by steering shoppers toward higher-priced products without losing its price edge. First-quarter 2026 results showed that
SNPS Rises 8.2% YTD: Should Investors Hold or Fold the Stock?
Synopsys, Inc. SNPS shares have appreciated 8.2% year to date, outperforming the Zacks Computer - Software industry’s decline of 6.9%.
SNPS YTD Performance Chart
Image Source: Zacks Investment
Five Reasons Lamar Advertising Stock Looks Worth Buying Now
Lamar Advertising Company LAMR is proving that outdoor advertising remains a strong and relevant business. The REIT opened 2026 on a positive note, beating expectations as local demand stayed
Do Options Traders Know Something About CBIZ Stock We Don't?
Investors in CBIZ, Inc. CBZ need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 17, 2026 $60 Call had some of the highest implied volatility
Voya's Unit Expands Alternative Investment Offerings With New CITs
Voya Financial, Inc.’s VOYA asset management business, Voya Investment Management (Voya IM), introduced two new multi-manager alternative collective investment trusts (CITs) for defined-contribution
Medtronic Q4 Earnings and Revenues Beat, Stock Rises in Pre-Market
Medtronic plc MDT posted fourth-quarter fiscal 2026 adjusted earnings of $1.55 per share, down 4.3% from the year-ago quarter but above the Zacks Consensus Estimate by 0.58%.
For full-year fiscal
Is the Options Market Predicting a Spike in Brixmor Property Stock?
Investors in Brixmor Property Group Inc. BRX need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 18, 2026 $20 Call had some of the highest
Jobs Week Helps Boost Market Sentiment
Wednesday, June 3rd, 2026
Jobs Week Coming Up Roses So Far: JOLTS, ADP
Don’t look now, but the labor market in the U.S. has demonstrably improved. Where we had been at historic lows on job openings
Block's Cash App Adds Afterpay BNPL: Will This Drive User Engagement?
Block XYZ recently announced the launch of Afterpay on Cash App Card, bringing eligible Cash App card customers under the sphere of Buy Now, Pay Later (“BNPL”). This arrangement has been designed
Manufacturing ETF (MADE) Hits New 52-Week High
iShares U.S. Manufacturing ETF MADE is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 51.38% from its 52-week low price of $25.30 per share.
Is BB Stock Still a Buy After a Triple-Digit Surge in 6 Months?
BlackBerry Limited’s BB shares have rallied 153.2% in the past six months, outperforming the Computer Software industry (down 6.8%) and the S&P 500 composite (rise of 10.9%). Yesterday, BB stock
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
If you are looking for a profitable portfolio of stocks offering the best of value and growth investing, you can try the growth at a reasonable price or GARP strategy.The strategy helps investors
GSK Bets on Specialty Medicines to Drive Long-Term Revenue Growth
GSK plc’s GSK Specialty Medicines business has become the company's primary growth engine, accounting for more than 40% of total sales and growing at a double-digit rate. The segment spans four core
5 HMO Stocks in Focus Amid an Aging U.S. Population, Tech Innovation
2 Domestic Auto Giants Worth Holding Despite Industry Weakness
Can AstraZeneca's Expanding Cancer Portfolio Sustain Momentum?
Over the past decade, AstraZeneca AZN has built a broad oncology franchise spanning multiple cancer types, including lung, breast, blood, gastrointestinal and genitourinary cancers. The segment
South Korea's Market Rally May Be Far From Over: ETFs to Consider
The strength of investor conviction in the AI theme can be seen in South Korea's market performance. The country has become one of Asia's standout growth stories, with its market rally gaining
AbbVie Gets EU Nod for Aquipta as Acute Treatment for Migraine
AbbVie ABBV announced that the European Commission has approved Aquipta (atogepant) for the acute treatment of migraine in adults with or without aura, to be taken as needed.
This marks the second
Stitch Fix (SFIX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when Stitch Fix (SFIX) reports results for the quarter ended April 2026. While this widely-known consensus
Chewy (CHWY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Chewy (CHWY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known consensus outlook is
Oracle (ORCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Oracle (ORCL) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended May 2026. This widely-known consensus outlook gives a
Best Momentum Stocks to Buy for June 3rd
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, June 3:
Dell Technologies Inc. DELL: This information technology solutions, products and
Does EquipmentShare.com Inc. (EQPT) Have the Potential to Rally 97.97% as Wall Street Analysts Expect?
Shares of EquipmentShare.com Inc. (EQPT) have gained 2.2% over the past four weeks to close the last trading session at $19.7, but there could still be a solid upside left in the stock if short-term



